1 Min Read
LONDON, Sept 26 (Reuters) - Imperial Innovations Group PLC : * portfolio company PsiOxus Therapeutics has launched the first clinical trial of its new anti-cancer vaccine, ColoAd1
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.